Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 12 juin 2024
May 10, 2024 01:00 ET
|
Nyxoah
INFORMATIONS RÉGLEMENTÉESle 10 mai 2024, 7:00h CET / 1:00h ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique(ci-après la « Société ») Invitation à...
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
May 10, 2024 01:00 ET
|
Nyxoah
REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to attend...
Shimmick Corporation Announces First Quarter 2024 Earnings Release Date and Conference Call
May 09, 2024 21:50 ET
|
Shimmick Corporation
IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Shimmick Corporation (“Shimmick”) (Nasdaq: SHIM), a leading water infrastructure company, today announced that the company will release its first...
Runway Growth Finance Corp. Announces Pricing of Secondary Offering of Common Stock by Selling Stockholder
May 09, 2024 20:50 ET
|
Runway Growth Finance Corp.
MENLO PARK, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (the “Company” or Runway Growth”), a specialty finance company focused on providing senior secured...
Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results
May 09, 2024 18:56 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 09, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery...
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2024 Financial Results on May 15, 2024
May 09, 2024 18:10 ET
|
TOMI Environmental Solutions, Inc.
FREDERICK, Md., May 09, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today...
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
May 09, 2024 17:46 ET
|
PDS Biotechnology Corporation
30 month median overall survival (OS); median OS independent of patient CPS score ORR 34% (CPS≥1); 48% (CPS≥20) Phase 3 registrational trial planned to initiate in 2024 PRINCETON, N.J., May 09,...
NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10
May 09, 2024 17:30 ET
|
NeOnc Technologies Holdings, Inc.
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc., a clinical stage biopharmaceutical company, is proud to be presenting at the 2024 California Investment Forum (CIF),...
Xtribe, Technology-driven Geolocation-based Commerce Platform, to Go Public on Nasdaq through Proposed Business Combination with WinVest Acquisition Corp. (NASDAQ: WINV)
May 09, 2024 17:26 ET
|
WinVest Acquisition Corp.
London, UK; Cambridge, MA, May 09, 2024 (GLOBE NEWSWIRE) -- Xtribe P.L.C. (“Xtribe”), a technology-driven platform that matches sellers of goods and services with local buyers, and WinVest...
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
May 09, 2024 17:25 ET
|
Phio Pharmaceuticals Corp.
–Four sites across the country participating in Phase 1b clinical trial for lead product candidate PH-762 –Three patients have been enrolled MARLBOROUGH, Mass., May 09, 2024 (GLOBE NEWSWIRE) --...